Joint pain affects millions of people worldwide, and for many, conventional treatments such as pain relief, physiotherapy and injections provide only partial or temporary relief. In recent years, regenerative medicine has emerged as a growing area of orthopaedic research, offering an approach that works differently: rather than managing symptoms, it aims to support the body’s own repair processes.
What is regenerative medicine?
Regenerative medicine refers to a broad range of treatments designed to stimulate or support the body’s natural ability to repair damaged tissue. In orthopaedics, it is most commonly applied to conditions involving cartilage degeneration, osteoarthritis, and chronic joint pain, areas where conventional medicine has traditionally struggled, in part because cartilage has very limited capacity for self-repair due to its poor blood supply.
Why cartilage is difficult to treat
Unlike bone or muscle, cartilage does not have a direct blood supply. This means that once it is damaged, the body has limited resources to repair it on its own. Over time, cartilage loss leads to the bone-on-bone friction characteristic of osteoarthritis, causing pain, stiffness and reduced mobility. Standard treatments can manage these symptoms, but they do not regenerate the tissue that has been lost.
Autologous adipose tissue: using your own body
One of the most studied regenerative techniques in orthopaedics involves the use of autologous adipose tissue, fat tissue taken from the patient’s own body. Adipose tissue contains stromal cells and biological factors that have attracted growing scientific interest for their potential role in tissue repair processes. Because the material comes from the patient themselves, the risk of rejection is eliminated.
The procedure is typically performed in a single session. A small amount of fat tissue is collected, processed, and reinjected into the affected joint, all in a controlled clinical environment. It is considered minimally invasive, with a relatively short recovery period compared to more extensive surgical interventions.
What the evidence shows
Research in this area is still evolving, and not all techniques carry the same level of scientific evidence. Some patients report meaningful improvements in pain and joint function in the months following treatment, while others see more modest results. Patient selection is critical: factors such as age, the stage of joint degeneration, overall health and individual expectations all influence outcomes.
Is it right for you?
Regenerative medicine is not suitable for everyone, and it is not a replacement for established treatments in cases where surgery is clearly indicated. The decision should always be made in consultation with a qualified specialist, who can assess your specific situation and recommend the most appropriate approach.
If your doctor has mentioned regenerative medicine as a potential option, it is worth asking about the specific technique proposed, the evidence behind it, what results are realistic in your case, and what the recovery process looks like.
References: Caplan AI. “Mesenchymal stem cells.” Journal of Orthopaedic Research, 1991 · Jevsevar DS. “Treatment of osteoarthritis of the knee.” Journal of the American Academy of Orthopaedic Surgeons, 2013 · Pas HI et al. “Stem cell injections in knee osteoarthritis.” British Journal of Sports Medicine, 2017 · AAOS Clinical Practice Guidelines, aaos.org.
